Cite
MLA Citation
Hans Wildiers et al.. “Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.” Lancet oncology, vol. 19, no. 3, 2018, pp. 323–336. http://access.bl.uk/ark:/81055/vdc_100057440631.0x000006